Green Park Collaborative and Allergy & Asthma Network Launch coreASTHMA to Develop Consensus on Critical Outcomes in Moderate to Severe Asthma Clinical Research
Retrieved on:
Tuesday, October 15, 2019
This initiative, coreASTHMA, will engage patients, clinicians, regulators, payers, health technology assessors, product developers, and other key stakeholders in a structured consensus process to develop the core outcome set.
Key Points:
- This initiative, coreASTHMA, will engage patients, clinicians, regulators, payers, health technology assessors, product developers, and other key stakeholders in a structured consensus process to develop the core outcome set.
- Asthma is a disease of chronic airway inflammation, with symptoms such as coughing, wheezing and shortness of breath impacting patients' daily functioning and quality of life.
- Despite multiple treatment options for management of asthma, many patients with severe or poorly controlled asthma fail to improve with existing treatments.
- "At this critical juncture, we want to ensure the patient voice translates to asthma research and policy decisions," said Tonya Winders, CEO of AAN.